Pharma News

The Indian biosimilar drugs industry is poised for exponential growth owing to the increasing acceptance, entry of new players, and successful launch of biosimilar products.

Study suggests that exenatide, currently used to treat type 2 diabetes, improves movement-related issues and might also slow the progression of the disease.

Los Angeles.

Drugmaker Eli Lilly and Co said on Friday its acute migraine drug lasmiditan succeeded in a key late-stage study, setting the stage for U.

The Food and Drug Administration (FDA) approved the first-ever drug that can treat all six major strains of hepatitis C (or HCV) in just eight weeks on Thursday.

The U.

The benefits of Johnson & Johnson's experimental rheumatoid arthritis drug sirukumab do not outweigh the risks, an advisory panel to the U.

SILVER SPRING, Md.

GENEVA (Reuters) - Yemen's cholera outbreak is far from being controlled and may be further exacerbated by the rainy season, even if the rate of new cases appears to be slowing in some hot...

Privately-held Italian company Dompé has had its marketing authorization application of cenegermin eye drops for the treatment of moderate to severe neurotrophic keratitis approved by the European Co...

On Thursday, the CEOs of Corning, Merck, and Pfizer pharmaceutical companies were welcomed to the White House by President Donald J.

A new treatment option has been approved in the European Union for patients with psoriasis, paving the way for access to a novel approach for those with moderate-to-severe forms of the disease who are...